申请人:Baba Masanori
公开号:US20120316342A1
公开(公告)日:2012-12-13
This invention provides a therapeutic agent for hepatitis C comprising, as an active ingredient, a compound having anti-HCV activity useful in treatment of hepatitis C. The therapeutic agent for hepatitis C comprises, as an active ingredient, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
这项发明提供了一种治疗丙型肝炎的药剂,其活性成分为具有抗丙型肝炎病毒活性的化合物,可用于治疗丙型肝炎。治疗丙型肝炎的药剂的活性成分包括由式(I)表示的化合物或其药用可接受的盐。